Clostridium pasteurianum carries three genes termed mopI, II and III encoding three molbindin isoforms, one of which has been cloned, the gene product expressed in high yield and crystallized using the hanging-drop vapour-diffusion method. Well ordered monoclinic crystals in two different crystal forms, both with space group C2, were obtained in the presence and absence of Na 2 MoO 4 and Na 2 WO 4 . Ligand-bound MopII crystallized with polyethylene glycol (PEG) 400 as a precipitant, whereas apo MopII required PEG 6000. Highresolution diffraction data were collected for ligand-bound MopII structures using synchrotron radiation to 1.8 and 1.6 A Ê resolution for the molybdate and tungstate complexes, respectively. Data were collected on apoMopII crystals to a resolution of 1.8 A Ê in-house.
Introduction
Molbindins are a class of low molecular weight proteins that speci®cally bind molybdate and which are implicated in the molybdenum metabolism of a variety of microorganisms (Grunden & Shanmugam, 1997; Lawson et al., 1997; Pau et al., 1998) . Three genes encoding molbindins have been identi®ed in the anaerobic nitrogen-®xing bacterium Clostridium pasteurianum (Hinton et al., 1987) and are denoted mopI, II and III. Early studies suggested that Mop proteins bound part of the molybdopterin cofactor; hence, they were ®rst described as molybdopterin-binding proteins (Hinton et al., 1987) . Homologues of the Mop sequence have been reported within a variety of bacterial proteins involved in molybdenum metabolism (Wagner et al., 2000; Gourley et al., 2001) . Crystal structures of Escherichia coli ModE (Hall et al., 1999) and Azotobacter vinelandii ModG (Delarbre et al., 2001) have revealed structural details of the molbindin domain and interactions with molybdate, subsequently leading to a classi®cation of molbindin structures (Gourley et al., 2001) . Recently, the crystal structure of a tungstateloaded Mop puri®ed from Sporomusa ovata was reported (Wagner et al., 2000) . In this study, the authors inadvertently puri®ed and crystallized a different protein to the one they were interested in but were able to make an assignment of sequence and classi®cation of the protein based on a careful interpetation of high-resolution electron-density maps.
At present, there has only been one report of a molbindin domain in the apo-form, that of the regulatory protein ModE (Hall et al., 1999) .
ModE has a C-terminal oxyanion-binding domain which consists of two Mop-like subdomains termed a DiMop unit, although only one of the subdomains is involved in binding the oxyanion ligand (Gourley et al., 2001) . ModE is dimeric and the binding of an oxyanion has been shown to induce conformational changes involving the DiMop oxyanion-binding domain which in¯uence the quaternary structure (Gourley et al., 2001) . Such a structural change may contribute to the highly speci®c biological function of ModE in regulating the oxyanion-dependent regulation of transcription. The Mop proteins are either trimers of DiMop-like subunits as exempli®ed by ModG (Delarbre et al., 2001) or trimers of Mop dimers as illustrated by the S. ovata Mop (Wagner et al., 2000) when loaded with oxyanions. There has not yet been any report of the structure of an apo Mop and our research will ultimately reveal the changes, if any, induced in Mop proteins by ligand binding.
We now describe the cloning of the C. pasteurianum mopII gene, the overexpression and puri®cation of the recombinant protein MopII and the crystallization and characterization of crystals of apoMopII together with molybdate and tungstate complexes.
Methods and materials 2.1. Cloning and expression of Clostridium pasteurianum MopII
The C. pasteurianum mopII gene was ampli®ed from genomic DNA by PCR using the 5 H -CAA-CTC-GAG-CAT-ATG-AGT-ATA-AGT-GCA-AGA-AA-3 H and 5 H -CGA-GGA-crystallization papers TCC-AAG-CTT-CAA-CTC-ATA-CTG-TGA-TAA-TTA-AGC-T-3 H speci®c oligonucleotide primers. These oligonucleotides (Hybaid) introduced restriction sites Nde1 and BamH1 (in bold). Pfu polymerase, T4 DNA ligase and restriction endonucleases were obtained from Promega. The PCR product was isolated by gel electrophoresis and puri®ed by gel extraction (Qiagen) and cloned into PCR4Blunt TOPO (M13 vector) using the zero blunt TOPO PCR cloning system (Invitrogen). Positive clones were con®rmed by DNA sequencing. The mopII gene was excized by restriction digest and ligated into the pET15b vector (Novagen). After the identity had been con®rmed, the plasmid was heat-shock transformed into E. coli BL21(DE3)pLysS (Novagen). A single colony was cultured to an OD 600 of approximately 0.6 in 1 l of LB broth containing ampicillin (100 mg ml À1 ) at 310 K, at which point isopropyl--d-thiogalactopyranoside (0.01 mM) was added to induce protein expression. Cells were grown for a further 16 h at 293 K then harvested by centrifugation (2600g) at 277 K.
Purification of C. pasteurianum MopII
Cells were resuspended in 50 mM Tris± HCl pH 7.6 and broken open by passage through a French press. The cell extract was ®ltered to 0.45 mm and applied to a metalchelating column (5 ml HiTrap, Amersham Pharmacia Biotech) which had been loaded with divalent nickel (using a nickel chloride solution) on a BioCAD 700E workstation.
The column was washed with 50 mM Tris±HCl pH 7.6 to remove any unbound protein.
The histidine-tagged protein was eluted in a gradient (0±500 mM) of imidazole in the same buffer. As MopII lacks a detectable chromophore, the protein was detected by Bradford assay and SDS±PAGE analysis. The fractions containing the protein were dialysed against 50 mM Tris±HCl pH 7.6, then incubated with thrombin (Amersham Pharmacia Biotech, 10 mg per milligram of protein) in 50 mM phosphatebuffered saline at room temperature overnight to remove the histidine tag. The protein was charged to a strong anionexchange (HQ Poros) column (Amersham Pharmacia Biotech) and eluted in a gradient of NaCl (0±500 mM). The fractions containing Mop were identi®ed (Bradford assay and SDS±PAGE), dialysed against Tris±HCl pH 8 overnight and the protein solution concentrated to 10 mg ml À1 for crystallization trials. The yield of protein was $30 mg l À1 of culture; the purity was con®rmed by SDS±PAGE (single band on a Coomassie-stained gel) and by MALDI-TOF mass spectrometry.
Crystallization of oxyanion-bound and apo C. pasteurianum MopII
Crystallization trials were initiated using commercially available screens (Hampton Research, USA) at different temperatures. The best results, which were subsequently optimized, for the oxyanion-bound protein were observed in Crystal Screen Cryo condition 14 and for the apo-protein were observed in Crystal Screen 2 condition 1.
Crystals of MopII complexed with tungstate ( Fig. 1) were grown at 293 K overnight from hanging drops consisting of 2 ml of protein solution, 2 ml of reservoir, 1 ml of 8 mM Na 2 WO 4 (®vefold molar excess relative to MopII) in 95 mM HEPES pH 7.5, 26.6%(w/v) polyethylene glycol 400, 5%(w/v) glycerol and 190 mM CaCl 2 . Well formed blocks, with maximum dimensions of 0.70 Â 0.05 Â 0.05 mm, are monoclinic in space group C2, with unit-cell parameters a = 56.37, b = 78.51, c = 94.84 A Ê , = 90.01 . The molybdate±MopII complex crystals were grown under similar conditions and are isomorphous, with unit-cell parameters a = 56.81, b = 78.38, c = 95.27 A Ê , = 90.01 . Crystals of the apo MopII (Fig. 1 ) grew overnight at 293 K in hanging drops consisting of 2 ml of protein stock solution and 2 ml of a reservoir solution consisting of 2 M NaCl and 10%(w/v) polyethylene glycol 6000. These crystals are also monoclinic with space group C2, but represent a different crystal form with unit-cell parameters a = 79.14, b = 82.47, c = 57.14 A Ê , = 93.38 .
X-ray measurements and data processing
The oxyanion-loaded MopII crystals were removed directly from the mother liquor and maintained in a nitrogen-gas stream at 100 K. High-resolution X-ray diffraction data were collected at the Synchrotron Radiation Facility, beamline PX9.6 (! = 0.89 A Ê ) at Daresbury, England from the tungstate-bound MopII crystals to a resolution of 1.6 A Ê and from molybdate-bound MopII to a resolution of 1.8 A Ê . The apoMop crystals were cryoprotected by soaking in 33%(v/v) glycerol for approximately 5 s before being placed in a nitrogen-gas stream at 100 K. X-ray diffraction data were collected in-house using an RU-200 Cu rotating-anode X-ray source (! = 1.5418 A Ê ) and an R-AXIS IV image-plate detector. Data were collected for the apo MopII to a resolution limit of 1.8 A Ê .
All data were processed with DENZO and scaled with SCALEPACK (Otwinowski & Minor, 1997) ; details are given in Table 1 . The Matthews coef®cients (Matthews, 1968) for MopII are calculated based on the assumption of six subunits, each of approximate molecular mass 7 kDa, per asymmetric unit. For the oxyanion-bound MopII, a Matthews coef®cient of 2.4 A Ê 3 Da À1 with $50% solvent content is estimated, whilst for apo MopII the coef®cient is 2.1 A Ê 3 Da À1 with a solvent content of $42%. Selfrotation function calculations (using POLARRFN; Collaborative Computational Project, Number 4, 1994; data not shown) indicate that a non-crystallographic threefold axis of symmetry is present in both crystal forms. This observation is consistent with the quaternary structure observed for the oxyanion-loaded Mop of S. ovata (Wagner et al., 2000) .
Several approaches are available to solve the structures of these crystal forms. 
crystallization papers
Molecular-replacement methods using the S. ovata WO 2À 4 -bound Mop (Wagner et al., 2000) or the E. coli ModE DiMop (Gourley et al., 2001; Hall et al., 1999) as initial search models could be attempted. However, an alternative approach, and one we favour since it could provide experimentally derived phase information, would exploit the anomalous scattering signal of tungsten (from the tungstate complex) either by itself or combined with the isomorphous differences with the molybdate complex. A difference Patterson function calculated on the basis of the tungstate and molybdate complex data (Table 1) shows well de®ned maxima (data not shown), which suggests that a single isomorphous replacement with anomalous scattering approach to phase determination should be successful.
In summary, we have obtained crystals of recombinant C. pasteurianum MopII complexed with the oxyanions molybdate or tungstate and also crystals of the apo protein. The crystals are well ordered, diffract to high-resolution and are suitable for full structural characterization of free and ligand-bound C. pasteurianum MopII to complement ongoing biochemical studies on the storage and utilization of molybdate.
